Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-006626
Filing Date
2022-02-16
Accepted
2022-02-16 16:05:22
Documents
1
Period of Report
2022-02-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4221
  Complete submission text file 0000899243-22-006626.txt   5663
Mailing Address 1 PLUCKEMIN WAY - SUITE 103 BEDMINSTER NJ 07921
Business Address 1 PLUCKEMIN WAY - SUITE 103 BEDMINSTER NJ 07921 212-461-2315
TYME TECHNOLOGIES, INC. (Issuer) CIK: 0001537917 (see all company filings)

EIN.: 453864597 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 44 WALL STREET 12TH FLOOR NEW YORK NY 10005
Business Address
Biehl James (Reporting) CIK: 0001710484 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38169 | Film No.: 22643558